blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1784227

EP1784227 - MR IMAGING METHOD FOR THE DISCRIMINATION BETWEEN HEALTHY AND TUMOUR TISSUE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.08.2012
Database last updated on 20.05.2024
Most recent event   Tooltip18.04.2014Lapse of the patent in a contracting state
New state(s): TR		published on 21.05.2014  [2014/21]
Applicant(s)For all designated states
GE HEALTHCARE AS
Intellectual Property Dept. PO Box 4220, Nydalen Nycoveien 1-2
0401 Oslo / NO
[N/P]
Former [2007/20]For all designated states
GE Healthcare AS
Intellectual Property Dept. PO Box 4220, Nydalen Nycoveien 1-2
0401 Oslo / NO
Inventor(s)01 / THANING, Mikkel
GE Healthcare AS
P.O. Box Nydalen
Nycoveien 1-2
N-0401 Oslo / NO
02 / ZANDT, René in't
Ekvägen 24
SE-247 36 Södra Sandby / SE
 [2011/38]
Former [2007/20]01 / THANING, Mikkel, Amersham Health R & D AB
P.A. Hanssons v. 41
S-205 12 Malmö / SE
02 / ZANDT, René in't, Amersham Health R & D AB
P.A. Hanssons v. 41
S-205 12 Malmö / SE
Representative(s)Wulff, Marianne Weiby, et al
GE Healthcare AS
Nycoveien 2
P.O. Box 4220 Nydalen
0401 Oslo / NO
[N/P]
Former [2010/31]Wulff, Marianne Weiby, et al
GE Healthcare AS Nycoveien 2 P.O. Box 4220 Nydalen
0401 Oslo / NO
Former [2007/20]Flechsler, Insa, et al
GE Healthcare Limited Amersham Place Little Chalfont
Bucks. HP7 9NA / GB
Application number, filing date05771198.828.07.2005
[2007/20]
WO2005NO00282
Priority number, dateNO2004000322630.07.2004         Original published format: NO 20043226
[2007/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006011810
Date:02.02.2006
Language:EN
[2006/05]
Type: A2 Application without search report 
No.:EP1784227
Date:16.05.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 02.02.2006 takes the place of the publication of the European patent application.
[2007/20]
Type: B1 Patent specification 
No.:EP1784227
Date:05.10.2011
Language:EN
[2011/40]
Search report(s)International search report - published on:EP13.04.2006
ClassificationIPC:G01R33/485, G01R33/56, A61B5/055, A61K49/06
[2011/40]
CPC:
G01R33/485 (EP); A61B5/055 (KR); A61K49/06 (KR);
A61K51/0406 (EP); G01R33/28 (KR); G01R33/5601 (EP)
Former IPC [2007/20]A61K49/06, A61B5/055, G01R33/20
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/20]
TitleGerman:MR-DARSTELLUNGSVERFAHREN ZUR DISKRIMINIERUNG ZWISCHEN GESUNDEM UND TUMORGEWEBE[2007/20]
English:MR IMAGING METHOD FOR THE DISCRIMINATION BETWEEN HEALTHY AND TUMOUR TISSUE[2007/20]
French:PROCEDE D'IMAGERIE DE TUMEURS[2007/20]
Entry into regional phase27.02.2007National basic fee paid 
27.02.2007Designation fee(s) paid 
27.02.2007Examination fee paid 
Examination procedure27.02.2007Examination requested  [2007/20]
01.06.2010Despatch of a communication from the examining division (Time limit: M04)
21.09.2010Reply to a communication from the examining division
06.05.2011Communication of intention to grant the patent
18.08.2011Fee for grant paid
18.08.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  01.06.2010
Opposition(s)06.07.2012No opposition filed within time limit [2012/37]
Fees paidRenewal fee
27.07.2007Renewal fee patent year 03
25.07.2008Renewal fee patent year 04
28.07.2009Renewal fee patent year 05
26.07.2010Renewal fee patent year 06
25.07.2011Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
FI05.10.2011
LT05.10.2011
LV05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
TR05.10.2011
BG05.01.2012
GR06.01.2012
IS05.02.2012
PT06.02.2012
[2014/21]
Former [2013/29]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
FI05.10.2011
LT05.10.2011
LV05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
BG05.01.2012
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2013/07]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
LT05.10.2011
LV05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
BG05.01.2012
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/36]BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
LT05.10.2011
LV05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
BG05.01.2012
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/35]BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
LT05.10.2011
LV05.10.2011
SE05.10.2011
SI05.10.2011
BG05.01.2012
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/34]BE05.10.2011
CY05.10.2011
CZ05.10.2011
LT05.10.2011
LV05.10.2011
SE05.10.2011
SI05.10.2011
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/28]BE05.10.2011
CY05.10.2011
LT05.10.2011
LV05.10.2011
SE05.10.2011
SI05.10.2011
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/24]BE05.10.2011
LT05.10.2011
LV05.10.2011
SE05.10.2011
SI05.10.2011
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/23]BE05.10.2011
LT05.10.2011
SI05.10.2011
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/21]BE05.10.2011
LT05.10.2011
SI05.10.2011
IS05.02.2012
Former [2012/20]LT05.10.2011
SI05.10.2011
Former [2012/11]SI05.10.2011
Cited inInternational search[A]US6466814  (ARDENKJAER-LARSEN JAN HENRIK [SE], et al) [A] 1-11,1-11,1-11 * column 13, line 21 - column 14, line 53 * * column 13, line 21 - column 14, line 53 * * column 13, line 21 - column 14, line 53 *;
 [E]EP1574874  (UNIVERSITAETSKLINIKUM FREIBURG [DE]) [E] 1,4,10,11,1,4,10,11,1,4,10,11 * paragraphs [0005] , [0006] * * paragraphs [0005] , [0006] * * paragraphs [0005] , [0006] *;
 [X]  - GOULD P., "C-13 MR tracers show potential for functional diagnostics", DIAGNOSTIC IMAGING, (200406), URL: http://www.diagnosticimaging.com/molecularimagingoutlook/2004jun/04.jhtml, (20060117), XP002363324 [X] 1-8,10,11,1-8,10,11,1-8,10,11 * the whole document * * the whole document * * the whole document *
 [PX]  - ALBERS M.J. ET AL, "A 13C HR-MAS Technique for Studying the Cellular Bioenergetics Associated with Prostate Cancer", PROCEEDINGS OF THE INTERNATIONAL SOCIETY FOR MAGNETIC RESONANCE IN MEDICINE, 13TH MEETING PROCEEDINGS, Miami Beach, Florida, USA, (20050507), page 2131, XP002363326 [PX] 1-8,10,11,1-8,10,11,1-8,10,11 * the whole document * * the whole document * * the whole document *
 [A]  - GOLMAN K ET AL, "Molecular imaging using hyperpolarized 13C.", THE BRITISH JOURNAL OF RADIOLOGY. 2003, (2003), vol. 76 Spec No 2, ISSN 0007-1285, pages S118 - S127, XP002363325 [A] 1-11,1-11,1-11 * page S119, column R, paragraph 2 * * page S119, column R, paragraph 2 * * page S119, column R, paragraph 2 *

DOI:   http://dx.doi.org/10.1259/bjr/26631666
 [A]  - WOLBER J ET AL, "Generating highly polarized nuclear spins in solution using dynamic nuclear polarization", NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH, SECTION - A: ACCELERATORS, SPECTROMETERS, DETECTORS AND ASSOCIATED EQUIPMENT, ELSEVIER, AMSTERDAM, NL, (20040621), vol. 526, no. 1-2, ISSN 0168-9002, pages 173 - 181, XP004830097 [A] 1-11,1-11,1-11 * chapters 4.1 and 4.3 * * chapters 4.1 and 4.3 * * chapters 4.1 and 4.3 *

DOI:   http://dx.doi.org/10.1016/j.nima.2004.03.171
 [A]  - GILLIES R.J., NMR in Physiology and Biomedicine, USA, ACADEMIC PRESS, (1994), XP002363328 [A] 1-11,1-11,1-11 *Chapter 19: Bhujwalla Z.M. et al, "MR Studies of Tumors: Relationship between Blood Flow, Metabolism and Physiology" * *Chapter 19: Bhujwalla Z.M. et al, "MR Studies of Tumors: Relationship between Blood Flow, Metabolism and Physiology" * *Chapter 19: Bhujwalla Z.M. et al, "MR Studies of Tumors: Relationship between Blood Flow, Metabolism and Physiology" *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.